| Trevor Scott Rachko, PMHNP, MSN | |
|
44882 Mission Rd, Pendleton, OR 97801-9293 | |
| (541) 429-0550 | |
| (541) 276-3093 |
| Full Name | Trevor Scott Rachko |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 44882 Mission Rd, Pendleton, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598316572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 201909432NP-PP (Oregon) | Primary |
| Entity Name | Bridge City Family Medical Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548330715 PECOS PAC ID: 7810988292 Enrollment ID: O20040524000631 |
News Archive
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.
In a recent study to determine why some individuals who experience symptoms for acute coronary syndrome decide to seek medical attention more quickly than others, a University of Oklahoma researcher has identified numeracy - the ability to understand and apply numerical concepts as the primary decision delay risk factor for individuals experiencing the medical condition.
Physicians and consumers agree that self-care is important to health and well-being, yet 75 percent of patients say they haven't discussed self-care with their physician within the last two years, according to a new survey released today, conducted by The Harris Poll on behalf of Samueli Integrative Health Programs.
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
› Verified 7 days ago
| Entity Name | Les Is More Mental Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295369841 PECOS PAC ID: 1759791684 Enrollment ID: O20201104003142 |
News Archive
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.
In a recent study to determine why some individuals who experience symptoms for acute coronary syndrome decide to seek medical attention more quickly than others, a University of Oklahoma researcher has identified numeracy - the ability to understand and apply numerical concepts as the primary decision delay risk factor for individuals experiencing the medical condition.
Physicians and consumers agree that self-care is important to health and well-being, yet 75 percent of patients say they haven't discussed self-care with their physician within the last two years, according to a new survey released today, conducted by The Harris Poll on behalf of Samueli Integrative Health Programs.
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trevor Scott Rachko, PMHNP, MSN 44882 Mission Rd, Pendleton, OR 97801-9293 Ph: (541) 429-0550 | Trevor Scott Rachko, PMHNP, MSN 44882 Mission Rd, Pendleton, OR 97801-9293 Ph: (541) 429-0550 |
News Archive
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.
In a recent study to determine why some individuals who experience symptoms for acute coronary syndrome decide to seek medical attention more quickly than others, a University of Oklahoma researcher has identified numeracy - the ability to understand and apply numerical concepts as the primary decision delay risk factor for individuals experiencing the medical condition.
Physicians and consumers agree that self-care is important to health and well-being, yet 75 percent of patients say they haven't discussed self-care with their physician within the last two years, according to a new survey released today, conducted by The Harris Poll on behalf of Samueli Integrative Health Programs.
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
› Verified 7 days ago
Wade Robert Hunsaker, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3001 St Anthony Way, Pendleton, OR 97801 Phone: 541-966-0535 Fax: 541-278-4597 | |
Mr. Theodore Phillip Chase, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2500 Westgate, Pendleton, OR 97801 Phone: 541-278-7128 | |
Miss Julie A Hughes, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1100 Southgate, Suite 9, Pendleton, OR 97801 Phone: 541-966-6916 | |
Seth Allen Alford, ARNP FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Yellowhawk Tribal Health Center, 46314 Timine Way, Pendleton, OR 97801 Phone: 541-966-9830 | |
Karen Marie Cook, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 73265 Confederated Way, Pendleton, OR 97801 Phone: 541-215-1965 Fax: 541-278-7572 | |
Mr. Joshua Kenji Raoul Hellstrom, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 44882 Mission Rd, Pendleton, OR 97801 Phone: 541-429-0550 | |
Katie C Morioka, WHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3001 St Anthony Way, #120, Pendleton, OR 97801 Phone: 541-966-0535 Fax: 541-278-4597 |